4.6 Review

A look at the ASEAN-NDI: building a regional health R&D innovation network

Journal

INFECTIOUS DISEASES OF POVERTY
Volume 3, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/2049-9957-3-15

Keywords

ASEAN-NDI; Health research and development; Infectious tropical diseases; Innovation network; Strategic business plan

Funding

  1. World Health Organization [001] Funding Source: Medline

Ask authors/readers for more resources

Globally, there are growing efforts to address diseases through the advancement in health research and development (R&D), strengthening of regional cooperation in science and technology (particularly on product discovery and development), and implementation of the World Health Assembly Resolution 61.21 (WHA61.21) on the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPA-PHI). As such, the Association of Southeast Asian Nations (ASEAN) is responding to this through the establishment of the ASEAN-Network for Drugs, Diagnostics, Vaccines, and Traditional Medicines Innovation (ASEAN-NDI). This is important in the ASEAN considering that infectious tropical diseases remain prevalent, emerging, and reemerging in the region. This paper looks into the evolution of the ASEAN-NDI from its inception in 2009, to how it is at present, and its plans to mitigate public health problems regionally and even globally.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available